a developer of peptide therapeutics for metabolic diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, RYTM has been loosely correlated with BBIO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RYTM jumps, then BBIO could also see price increases.
Ticker / NAME | Correlation To RYTM | 1D Price Change % | ||
---|---|---|---|---|
RYTM | 100% | -2.83% | ||
BBIO - RYTM | 45% Loosely correlated | +3.20% | ||
KURA - RYTM | 45% Loosely correlated | -4.04% | ||
NTLA - RYTM | 44% Loosely correlated | -3.65% | ||
VRDN - RYTM | 42% Loosely correlated | -1.43% | ||
RLAY - RYTM | 41% Loosely correlated | -4.71% | ||
More |
Ticker / NAME | Correlation To RYTM | 1D Price Change % |
---|---|---|
RYTM | 100% | -2.83% |
peptide theme (2 stocks) | 99% Closely correlated | -5.39% |
drugs theme (265 stocks) | 50% Loosely correlated | +5.37% |
biotechnology theme (248 stocks) | 49% Loosely correlated | +5.56% |
metabolic theme (5 stocks) | 40% Loosely correlated | +0.71% |